Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001047469-16-013282
Filing Date
2016-05-19
Accepted
2016-05-18 21:51:50
Documents
9
Period of Report
2016-06-01

Document Format Files

Seq Description Document Type Size
1 PREM14A a2228684zprem14a.htm PREM14A 3778112
2 G649547.JPG g649547.jpg GRAPHIC 11059
3 G448689.JPG g448689.jpg GRAPHIC 64594
4 G10180.JPG g10180.jpg GRAPHIC 60473
5 G635117.JPG g635117.jpg GRAPHIC 118994
6 G801299.JPG g801299.jpg GRAPHIC 86162
7 G140729.JPG g140729.jpg GRAPHIC 8121
8 G142733.JPG g142733.jpg GRAPHIC 2884
9 G360912.JPG g360912.jpg GRAPHIC 9362
  Complete submission text file 0001047469-16-013282.txt   4278217
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 001-33277 | Film No.: 161661807
SIC: 2834 Pharmaceutical Preparations